Conformality limits of 2D WS 2 on 3D nanostructures
Nanoscale · 2025 · 17 (28) · 16922-16927
DOI: 10.1039/d5nr01013f ↗Kurz gefasst
Fachartikel in der Zeitschrift Nanoscale, 2025. Verfasst von Jeff J P M Schulpen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Physics and Science Education, Eindhoven University of Technology, Eindhoven 5600 MB, the Netherlands. aabol@umich.edu. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Provincie Noord-Brabant, Nederlandse Organisatie voor Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
A critical radius of curvature of 4 nm for conformal deposition of WS 2 on 3D nanostructures was identified, offering design guidelines for integrating 2D transition metal dichalcogenides in advanced nanoelectronic and catalytic applications.
Autor:innen und Institutionen
- Department of Applied Physics and Science Education, Eindhoven University of Technology, Eindhoven 5600 MB, the Netherlands. aabol@umich.edu.
- Eurofins Materials Science BV, High Tech Campus, Eindhoven 5656 AE, the Netherlands.
- Department of Chemistry, University of Michigan, Ann Arbor, MI 48109, USA.
Förderung
- Provincie Noord-Brabant
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Zitieren
APA
Schulpen, J. J. P. M., Basuvalingam, S. B., Verheijen, M. A., & Bol, A. A. (2025). Conformality limits of 2D WS 2 on 3D nanostructures. Nanoscale, 17(28), 16922-16927. https://doi.org/10.1039/d5nr01013f
Vancouver
Schulpen JJPM, Basuvalingam SB, Verheijen MA, Bol AA. Conformality limits of 2D WS 2 on 3D nanostructures. Nanoscale. 2025;17(28):16922-16927. doi:10.1039/d5nr01013f
BibTeX
@article{Schulpen2025,
author = {Schulpen, Jeff J P M and Basuvalingam, Saravana B and Verheijen, Marcel A and Bol, Ageeth A},
title = {Conformality limits of 2D WS 2 on 3D nanostructures},
journal = {Nanoscale},
year = {2025},
volume = {17},
number = {28},
pages = {16922--16927},
doi = {10.1039/d5nr01013f}
}
EUVIMED